Doximity (DOCS) Q2 2026 Earnings

Yes. Doximity reported Q2 2026 earnings of $0.45 a share on Nov 6, 2025, beating the $0.38 consensus estimate by 18.7%. Revenue was $168.5M against a $157.6M estimate.

Doximity turned in a standout fiscal second quarter for 2026, posting revenue of $168.53 million — up 23.2% year-over-year and well ahead of the $157.59 million consensus — while non-GAAP diluted EPS of $0.45 beat the $0.38 estimate by 18.70%, reflecting the kind of operating leverage that has become a hallmark of the physician network platform. The single most material driver behind the beat was margin expansion: adjusted EBITDA reached $100.83 million, pushing margins to 59.8% from 55.7% a year ago, as revenue acceleration outpaced cost growth. AI engagement was a notable catalyst, with AI Scribe and DoxGPT users growing over 50% from the prior quarter and a record 650,000 prescribers tapping Doximity's workflow tools — a dynamic that stands in contrast to <a href="https://247wallst.com/investing/2025/12/04/docusign-shares-sell-off-despite-despite-strong-fy26-q3-earnings/">other software companies struggling</a> to translate strong results into investor confidence. Management raised full-year fiscal 2026 revenue guidance to $640–$646 million and guided Q3 revenue of $180–$181 million, signaling continued momentum through the seasonally important back half of the year.